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Abstract
Background: The aim of this study was to investigate the dosimetric quality in volumetric modulated arc therapy
(VMAT) plans with optimal collimator angles that can represent the outline of multiple brain targets.
Methods: Twenty patients with multiple target volumes in the brain cases were selected retrospectively. To better
represent the outline of the multiple brain targets, four conformal arc plans were generated for each patient using
one full arc with four collimator settings. The optimal collimator angles calculated from the integrated multi-leaf
collimator (MLC) aperture that had the smallest aperture size for certain collimator settings of the conformal arc
plan were selected. VMAT plans with the optimal collimator angles with angular sections of 40° and 60° (Colli-VMAT
(40°), Colli-VMAT (60°)) were generated, followed by evaluation of field sizes, dose-volumetric parameters and total
monitor units (MUs).
Results: Patient-averaged values of field sizes for Colli-VMAT (40°) (111.5 cm2) were lowest and 1.3 times smaller
than those for Std-VMAT (143.6 cm2). Colli-VMAT plans improved sparing of most normal organs but for brain stem
and left parotid gland. For the total MUs, the averaged values obtained with the Colli-VMAT (40°) (390 ± 148 MU)
were smaller than those obtained with the Std-VMAT (472 ± 235 MU).
Conclusions: The Colli-VMAT plans with smaller angular sections could be suitable in the clinic for multiple brain
targets as well as for irregularly shaped targets. Determination of the optimal collimator rotation generally showed
good normal tissue sparing and MU reduction for multiple brain targets.
Background
Volumetric modulated arc therapy (VMAT) can achieve
highly conformal dose distribution to target volumes
while sparing normal tissues, using intensity-modulated
photon beams by simultaneous modulations of multi-
leaf collimator (MLC) positions, gantry rotation speed,
and dose-rate [1, 2]. Planning studies have consistently
demonstrated that VMAT plans show equivalent dosi-
metric plan quality and usually reduce monitor unit
(MU) usage compared to intensity-modulated radiation
therapy (IMRT) [3–5]. Because of these reasons, VMAT
has been widely used for various treatment sites clinic-
ally [6–11].
Collimator angle is an important parameter that af-
fects dosimetric plan quality; however, the current tech-
nology does not allow collimator rotation during VMAT
delivery, and thus, a single optimal collimator angle
must be selected. The optimal collimator angle can be
determined manually based on the user’s experience to
consider target shape, size, and placement in the clinic.
Several studies have reported that a collimator angle of
45° has been appropriate in most cases and acquired bet-
ter dosimetric plan quality than other angles [1, 5, 12].
In Eclipse™ (Varian Medical Systems, Palo Alto, CA), the
recommended collimator angles for VMAT plan
optimization are collimator rotations of 10° (350°) and
30° (330°) for most cases [13].
In order to evaluate the effectiveness of dynamic colli-
mator angle during VMAT delivery, Boer et al. adjusted
the collimator and gantry angle for considering left-right
prostate rotation [14]. They reported that the left-right
prostate rotation could be compensated with this tech-
nique. Zhang et al. proposed a collimator trajectory
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optimization algorithm based on a principal component
calculated from a beam’s-eye view (BEV) of the spinal
cord [15]. These values of principal component could
provide the long axis of the cord and then suitable MLC
direction could be selected. These studies have shown
dosimetric improvement compared to VMAT plans with
a fixed collimator angle.
In a previous study, we analyzed the dosimetric effects
of optimal collimator angles at each sectional arc in the
VMAT for an irregularly shaped target in abdominal,
head and neck, and chest cases [16]. In that study, the
optimal collimator angles were calculated using an inte-
grated MLC aperture from a conformal arc plan gener-
ated with a fixed collimator setting of 0°. Although we
demonstrated considerable improvements of dosimetric
plan quality and MU efficiency using the optimal colli-
mator angles, the integrated MLC apertures with a fixed
collimator setting of 0° had limitations that could not
fully express the shape of the targets defined by the
MLCs [16]. For multiple brain targets, the conformal arc
plans with a fixed collimator angle of 0° used in our pre-
vious study were not appropriate. If we can represent all
the outlines of the targets using the MLC apertures re-
gardless of shape, size, and placement of the targets, the
optimal collimator angles calculated from these inte-
grated MLC apertures might have better potential to
improve the dosimetric plan quality or MU efficiency.
In this study, we attempted to generate the integrated
MLC apertures from various collimator settings, and
then calculated the optimal collimator angles using these
integrated MLC apertures for multiple brain targets. We
tested the performance of this technique and then
compared the dosimetric plan quality and total MUs to
those obtained in our previous study, as well as the con-




Twenty patients with multiple target volumes in the
brain were retrospectively selected. All had been previ-
ously treated with radiotherapy at our institution. An ap-
proval for this study was obtained from the institutional
review board (IRB No. 1612–013-811). The maximum
number of multiple target volumes was 5 and maximum
distance between multiple target volumes was 11.9 cm
with averaged value of 6.8 cm. The 20 patients were
given 5 to 28 fractions with prescription doses ranging
from 15.0 Gy to 50.4 Gy. The patient characteristics are
summarized in Table 1.
Determination of optimal collimator angles
In this study, the commercial treatment planning system,
Eclipse™ version 10 (Varian Medical Systems, Palo Alto,
CA), was used. In order to obtain the MLC apertures for
the multiple brain targets and then generate the inte-
grated MLC apertures within angular sections, four con-
formal arc plans were generated for each patient using
one full arc with four collimator settings of 0°, 45°, 90°,
and 135°, respectively. The number of control points
(CPs) for each conformal arc plan was 500, which is the
maximum value obtained with 0.72°/CP spacing. Four
conformal arc plans were exported in DICOM-RT for-
mat from Eclipse™. The MLC positions represented as
the outline of the target for each CP were obtained using
an in-house program written in MATLAB (R2016a,
Mathworks, Inc., Natick, MA).
In our previous study, we determined the optimal
collimator angles with various angular sections using the
conformal arc plans with a fixed collimator angle of 0°
and then demonstrated that VMAT plans with the opti-
mal collimator angles with angular sections of 40° and
60° (Colli-VMATPre (40°), Colli-VMATPre (60°)) reduced
the total MUs and improved the sparing of normal or-
gans, compared to Colli-VMATPre (90°), Colli-VMATPre
(120°), and Std-VMAT [16]. Std-VMAT plan was one
full-arc VMAT plans with a fixed collimator angle,
having an angular section of 360°. The fixed collimator
angle for Std-VMAT plans was calculated using the
Table 1 Patient characteristics








1 2 6.5 30.0 10
2 2 5.6 30.0 10
3 2 5.4 30.0 10
4 5 8.7 18.0 6
5 4 11.9 20.0 5
6 3 9.0 18.0 10
7 2 7.0 21.6 12
8 3 7.6 45.0 25
9 2 10.4 35.0 10
10 4 11.3 15.0 5
11 2 6.0 36.0 20
12 2 8.2 36.0 12
13 2 4.0 45.0 25
14 2 7.5 50.4 28
15 2 4.2 45.0 25
16 2 5.0 50.4 28
17 2 4.0 27.0 9
18 2 5.4 15.0 5
19 2 4.1 50.4 28
20 2 4.1 50.4 28
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same procedure as that for calculating the optimal colli-
mator angle of Colli-VMATPre plans.
In this study, angular sections of 40° and 60° were
chosen while the VMAT plans had sectional arcs (partial
arc field) of 9 and 6 according to the angular sections of
40° and 60°, respectively. The integrated MLC apertures
were determined by the MLC positions having the lar-
gest gap within the angular section to cover the target
volumes based on the beam’s-eye view (BEV). For each
of the sectional arcs in the VMAT plan, the aperture
sizes of the integrated MLC apertures from the con-
formal arc plans with four collimator settings of 0°, 45°,
90°, and 135° were compared. Of these collimator set-
tings, the integrated MLC apertures that had the smal-
lest aperture size for a certain collimator setting of the
conformal arc plan were selected. Figure 1 demonstrates
the integrated MLC apertures for different collimator
settings of the conformal arc plans and proper collima-
tor setting can represent the shape of multiple brain tar-
gets exactly within the angular section.
With the integrated MLC apertures chosen in this
study, we obtained the optimal collimator angles by min-
imizing the area size difference between the integrated
MLC aperture and the collimator settings. As the
collimator rotated, the collimator settings had 5-mm
margins to the integrated MLC aperture. Figure 2 de-
scribes the more detailed procedure to calculate optimal
collimator angle and an example of area size difference
between the integrated MLC apertures and collimator
settings. This process was repeated to calculate the opti-
mal collimator angle for each sectional arc. The VMAT
plans suggested in this study according to the angular sec-
tions of 40° and 60° (Colli-VMAT (40°) and Colli-VMAT
(60°)) were generated in Eclipse™. For comparison pur-
poses, Colli-VMATPre (40°), Colli-VMATPre (60°), and
Std-VMAT plans were generated.
In the same manner as our previous study [16], some
of the calculated optimal collimator angles for sectional
arcs were re-determined by adding 90° rotation to those
calculated optimal collimator angles before VMAT plan
optimization. The reason for adding 90° rotation is that
the collimator angle added to 90° rotation could poten-
tially reduce the burden of MLC control for modulating
photon beam intensity owing to the maximum leaf span
of the MLCs (15 cm). If the maximum distance in the
integrated MLC apertures exceeded the maximum leaf
span in the MLC direction, the collimator angles added
to 90° were re-chosen as the optimal collimator angles
to improve the target conformity.
VMAT plans for multiple brain targets
All VMAT plans were created with 6 MV photon beams
from Trilogy™ with Millennium™ 120 MLC (Varian
Medical Systems, Palo Alto, CA). Every VMAT plan was
optimized with the progressive resolution optimizer 3
(PRO3, ver. 10, Varian Medical Systems, Palo Alto, CA).
To acquire better dosimetric plan quality, all VMAT
plans were re-optimized using current dose distribution
as the reference. The dose distributions were calculated
by using the anisotropic analytic algorithm (AAA, ver.
10, Varian Medical Systems, Palo Alto, CA) with a calcu-
lation grid of 1 mm to remove the calculation grid de-
pendency. All plans were normalized so that 95% of the
prescription dose covered 100% of the target volume.
Dosimetric analysis and evaluation
The dose-volume histogram (DVH) data was used to
evaluate the dosimetric quality with respect to target
coverage and dose received by normal organs. For the
target volumes, the evaluated dose-volumetric parame-
ters were the mean dose, maximum dose, minimum
dose, dose received by at least 99% volume of the target
Fig. 1 Beam’s-eye view (BEV) of target volumes with multiple brain targets fitted by multi-leaf collimators (MLCs) at collimator settings of 0° (a)
and 90° (b)
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volume (D99%), D95%, D5%, D1%, conformity index (CI),
homogeneity index (HI), and gradient measure (GM).
The CI, HI, and GM are defined as follows [2, 17–19]:
Conformity index CIð Þ ¼ Volume of reference isodose
Volume of target volume
;
ð1Þ




Gradient measure GMð Þ ¼ R50%of presecription dose−Rpresecription dose;
ð3Þ
where the volume of reference isodose is the volume irra-
diated by 95% of the prescription dose, and Rx is the
sphere radius of which the volume is the same as the
volume of isodose of x.
For the normal organs, the following were calculated:
the absolute volume of a normal brain without target
volumes irradiated by at least 5 Gy (V5 Gy), V12 Gy, and
V15 Gy; the mean dose of a normal brain without target
volumes; the maximum dose of the spinal cord, brain
stem, optic chiasm, right and left optic nerves, and right
and left lenses; and the mean dose of the right and left
parotid glands.
Averaged total MUs were compared and MU reduc-
tion was calculated to evaluate the relative delivery effi-
ciency of each VMAT plan. The MU reduction is
defined as




where MUcolli-VMAT and MUStd-VMAT are total MUs for
Colli-VMAT and Std-VMAT, respectively.
For multiple comparison statistics, the patient-averaged
values of field sizes, DVH data, and total MUs were
analyzed with one-way analysis of variance (ANOVA) with
the Bonferroni correction and then Bonferroni-adjusted
p-values were calculated. Significance was defined as
p < 0.05 for 10 pairwise comparisons. All analysis was
performed by SPSS version 14.0 (SPSS Inc., Chicago, IL).
Results
Field sizes for optimal collimator angle
After obtaining the optimal collimator angles for Std-
VMAT plan, Colli-VMATPre plans, and Colli-VMAT
plans, field sizes according to these sectional arcs
were calculated and averaged for each patient, as
shown in Table 2. The patient-averaged values of the
field size were 143.6 cm2 ± 60.8 cm2, 113.5 cm2 ± 49.7 cm2,
114.8 cm2 ± 50.9 cm2, 111.5 cm2 ± 48.8 cm2, and 115.
1 cm2 ± 49.4 cm2 for Std-VMAT, Colli-VMATPre (40°),
Colli-VMATPre (60°), Colli-VMAT (40°), and Colli-VMAT
(60°), respectively. The p-values for one-way analysis of
variance (ANOVA) with Bonferroni multiple comparison
of the patient-averaged values of the field sizes are shown
in Table 2. The patient-averaged values of the field sizes
for Colli-VMATPre (40°) and Colli-VMAT (40°) de-
monstrated improved results with an average of 26.5 and
28.8% reductions with statistical significance (p = 0.001
and p = 0.001, respectively), compared with Std-VMAT.
For Colli-VMAT (40°) and Colli-VMAT (60°) plans, the
values of the field sizes had decreasing tendencies when
the values of angular sections became smaller with statis-
tical significance (p = 0.015). When comparing Colli-
VMATPre (40°) to Colli-VMAT (40°), there were slight
decreasing tendencies in the values of the field sizes,
Fig. 2 Detailed procedure for generation of integrated multi-leaf
collimators (MLC) aperture and determination of optimal collimator
angle (a) and an example of area size difference between the
integrated MLC aperture and collimator settings (b) with 5-mm
margins to the integrated MLC aperture according to collimator
angles in Field 2 (Sectional arc 2)
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which were statistically significant in our current study
(p = 0.023).
Dosimetric analysis and evaluation
The patient-averaged values of dose-volumetric parame-
ters of Std-VMAT plan, Colli-VMATPre plans, and Colli-
VMAT plans for multiple brain targets and normal
tissues are shown in Table 3.
For multiple brain targets, the patient-averaged values
of D99%, D95%, D5%, D1%, minimum dose, maximum
dose, mean dose, conformity index, homogeneity index,
and gradient measure for target volume were similar
regardless of the VMAT plans, with no statistical
significance in all the VMAT plans compared. For more
detailed results, the patient-averaged values of dose-
volumetric parameters for normal organs were obtained
and the p-values for one-way analysis of variance
(ANOVA) with Bonferroni multiple comparison of the
patient-averaged values of dose-volumetric parameters
were also calculated by comparing Std-VMAT, Colli-
VMATPre (40°), and Colli-VMAT (40°), and are listed
in Table 4.
Table 2 Patient-averaged values of field sizes according to the optimal collimator angles, and p values for one way analysis of
variance (ANOVA) with Bonferroni multiple comparison test of the patient-averaged values of field sizes
Std-VMAT Colli-VMATPre (40°) Colli-VMATPre (60°) Colli-VMAT (40°) Colli-VMAT (60°)
Average (cm2) 143.6 ± 60.8 113.5 ± 49.7 114.8 ± 50.9 111.5 ± 48.8 115.1 ± 49.4
Bonferroni adjusted p-values
Colli-VMATPre (40°) 0.001 – – – –
Colli-VMATPre (60°) 0.005 – – – –
Colli-VMAT (40°) 0.001 0.023 0.037 –
Colli-VMAT (60°) 0.002 – – 0.015 –
Table 3 Averaged values of dose-volumetric parameters
Structure DV parametera Std-VMAT Colli-VMATPre (40°) Colli-VMATPre (60°) Colli-VMAT (40°) Colli-VMAT (60°)
Target volume D99%
b (Gy) 28.8 ± 11.9 28.6 ± 11.6 28.7 ± 11.7 28.6 ± 11.6 28.7 ± 11.7
D95% (Gy) 29.4 ± 12.4 29.2 ± 12.2 29.3 ± 12.4 29.3 ± 12.2 29.4 ± 12.2
D5% (Gy) 32.3 ± 15.4 32.4 ± 15.1 32.3 ± 15.4 32.4 ± 15.1 32.2 ± 15.0
D1% (Gy) 32.6 ± 15.7 32.7 ± 15.2 32.6 ± 15.5 32.7 ± 15.2 32.4 ± 15.1
Minimum dose (Gy) 21.4 ± 10.0 22.0 ± 10.1 21.4 ± 10.0 22.1 ± 9.9 21.1 ± 10.1
Maximum dose (Gy) 33.2 ± 14.3. 33.1 ± 14.4 33.2 ± 15.3. 33.0 ± 15.4 33.1 ± 15.3
Mean dose (Gy) 31.1 ± 15.0 31.4 ± 14.4 31.4 ± 15.0 31.4 ± 15.3 31.3 ± 15.4
Conformity index 0.8 ± 0.1 0.8 ± 0.1 0.8 ± 0.1 0.8 ± 0.1 0.8 ± 0.1
Homogeneity index 0.09 ± 0.02 0.10 ± 0.06 0.09 ± 0.03 0.10 ± 0.04 0.10 ± 0.02
Gradient measure (cm) 1.3 ± 0.2 1.4 ± 0.1 1.3 ± 0.1 1.4 ± 0.1 1.3 ± 0.1
Normal brain - PTV V5 Gy
c (cc) 776.6 ± 316.3 778.0 ± 320.1 783.4 ± 320.4 764.6 ± 318.2 766.0 ± 313.3
V12 Gy (cc) 454.5 ± 333.4 443.3 ± 340.7 448.7 ± 342.9 439.5 ± 341.1 441.1 ± 335.8
V15 Gy (cc) 357.3 ± 333.4 351.5 ± 340.7 356.7 ± 342.9 347.5 ± 341.1 348.5 ± 335.8
Mean dose (Gy) 13.4 ± 9.9 13.3 ± 10.0 13.4 ± 10.0 13.2 ± 10.1 13.1 ± 9.7
Spinal cord Maximum dose (Gy) 3.6 ± 2.0 3.2 ± 2.8 3.1 ± 2.2 1.8 ± 2.5 3.1 ± 2.9
Brain stem Maximum dose (Gy) 26.6 ± 15.3 26.6 ± 16.6 26.6 ± 16.7 26.4 ± 16.5 26.3 ± 15.9
Optic chiasm Maximum dose (Gy) 26.4 ± 11.5 25.7 ± 11.5 25.5 ± 11.6 25.0 ± 12.0 25.3 ± 11.3
Right optic nerve Maximum dose (Gy) 19.6 ± 16.8 18.5 ± 16.3 18.4 ± 16.9 17.7 ± 16.8 18.0 ± 17.0
Left optic nerve Maximum dose (Gy) 19.6 ± 17.5 17.8 ± 16.6 18.4 ± 17.0 17.6 ± 16.8 18.2 ± 17.5
Right lens Maximum dose (Gy) 3.5 ± 2.2 3.4 ± 3.0 3.4 ± 2.8 3.0 ± 3.1 3.0 ± 2.0
Left lens Maximum dose (Gy) 3.1 ± 1.9 3.0 ± 2.0 3.2 ± 2.3 2.8 ± 2.0 3.0 ± 1.7
Right parotid Mean dose (Gy) 0.9 ± 1.2 0.8 ± 1.3 0.8 ± 1.2 0.7 ± 1.1 0.8 ± 1.2
Left parotid Mean dose (Gy) 1.0 ± 1.2 1.1 ± 1.2 1.1 ± 1.0 1.1 ± 1.2 1.1 ± 1.0
aDV parameter = dose-volumetric parameter
bDn% = dose received at least n% volume of a structure
cVn Gy = absolute volume irradiated by at least n Gy of a structure
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For comparison of Std-VMAT with Colli-VMATPre
(40°) and Colli-VMAT (40°), most of the dose-volumetric
parameters of normal tissues for Colli-VMAT (40°) and
Colli-VMATPre (40°) were lower than those for Std-
VMAT and showed statistical significance. The patient-
averaged mean doses for the left parotid gland were
similar regardless of the VMAT plans. When comparing
Colli-VMAT (40°) to Colli-VMATPre (40°), the patient-
averaged maximum dose for spinal cord, brain stem, optic
chiasm, right optic nerves, and right lens, and the patient-
averaged mean doses, V5 Gy. V12 Gy and V15 Gy for normal
brain without target volumes had slight decreasing ten-
dencies with statistical significance. Figure 3 demonstrates
the dose-volume histograms (DVHs) for the representative
patient case (Patient #11). There was a slight improve-
ment of the target volume coverage with a reduction of
maximum dose in the target volume. For the DVHs of
normal tissues, the dose received by all the normal tissues
shows a decreasing tendency when Colli-VMAT (40°) was
applied. The maximum dose deviation between Colli-
VMAT (40°) and Std-VMAT was 7.2 Gy for the DVH of
optic chiasm.
The averaged total MUs with respect to Std-VMAT, Colli-
VMATPre (40°), Colli-VMATPre (60°), Colli-VMAT (40°),
and Colli-VMAT (60°) were 472 ± 235 MU, 400 ± 154 MU,
419 ± 168 MU, 390 ± 148 MU, and 417 ± 167 MU, respect-
ively, and the p-values for for one-way analysis of variance
(ANOVA) with Bonferroni multiple comparison of the
patient-averaged values of the dose-volumetric parameters
were calculated for statistical analysis, as detailed in
Table 5. The results of the averaged total MUs were
statistically significant except for comparisons between
Colli-VMATPre (40°) and Colli-VMAT (60°) (p = 0.057),
and between Colli-VMATPre (60°) and Colli-VMAT
(60°) (p = 0.356). The values of the averaged total MUs
for Colli-VMATPre plans and Colli-VMAT plans were
smaller than those for the Std-VMAT plan, with statistical
significance. When the Colli-VMAT (40°) plan was used,
the averaged total MU was lowest.
Discussion
In a previous study, we demonstrated the potential of
optimal collimator angles during the VMAT delivery for
abdomen, head and neck, and chest cases, all of which
had an irregularly shaped target, showing high reduction
of the total MUs and improvement of dosimetric plan
quality, compared to a fixed collimator angle. In that
study, Colli-VMATPre plans with angular sections of 40°
could cover the large and irregularly shaped target, and
by using a DICOM-RT format file of the conformal arc
plan with a collimator setting of 0°, the optimal collima-
tor angles could be calculated effectively [16]. However,
as mentioned above, MLC positions in the conformal
arc plans generated with a collimator setting of 0° could
not fully express the target outline. In the case of mul-
tiple targets, in particular for brain cases, shapes of the
multiple brain targets defined by the MLC positions
could be greatly changed according to the collimator set-
tings. In this study, we acquired conformal arc plans
with four collimator settings of 0°, 45°, 90°, and 135° to
find a realistic outline of the multiple brain targets irre-
spective of the collimator angles. With this technique,
Table 4 p values for one way analysis of variance (ANOVA) with Bonferroni multiple comparison test of the patient-averaged values
of dose-volumetric parameters
Bonferroni adjusted p-values






Normal brain - PTV V5 Gy
b (cc) < 0.001 < 0.001 < 0.001
V12 Gy (cc) 0.002 0.023 0.036
V15 Gy (cc) < 0.001 < 0.001 0.024
Mean dose (Gy) – – –
Spinal cord Maximum dose (Gy) 0.025 0.018 0.015
Brain stem Maximum dose (Gy) – – 0.048
Optic chiasm Maximum dose (Gy) – 0.043 0.033
Right optic nerve Maximum dose (Gy) 0.025 0.035 0.016
Left optic nerve Maximum dose (Gy) 0.023 0.036 –
Right lens Maximum dose (Gy) – 0.042 0.048
Left lens Maximum dose (Gy) – – –
Right parotid Mean dose (Gy) 0.025 – –
Left parotid Mean dose (Gy) – – –
aDV parameter = dose-volumetric parameter
bVn Gy = The absolute volume of a structure irradiated by at least n Gy
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the outlines of multiple brain targets could be properly
acquired. DICOM-RT structure files contained point
clouds in xyz format to represent the real geometry of
target volumes. However, there was a limitation for
obtaining the 2D outline of the target volume on any
plane defined by BEV. In order to perform 2D
interpolation to a 3D surface, several models to generate
3D triangulated meshes should be used, which is compli-
cated and time-consuming. For that reason, conformal arc
plans to simply obtain the outline of the target volume
were used in this study. For dosimetric evaluation, dose
distributions in Colli-VMATPre (40°) and Colli-VMAT
(40°) for multiple brain targets are shown in Fig. 4. The
MLC apertures used in this study to represent realistic
brain targets showed dose reduction in normal brain,
compared to those in the previous study [16]. The
technique proposed in this study could reduce un-
necessary dose exposure to the normal brain with similar
plan quality. However, the four collimator settings and
MLC positions still had limitations that could not fully
represent the various shapes and the number of targets.
Furthermore, target contouring information will be used
Fig. 3 Examples of dose-volume histograms (DVH) of target volumes (a), optic chiasm (b), brain stem (c), and normal brain minus target volume
(d) for multiple brain targets. The solid lines represent the DVHs of Colli-VMAT plans with an angular section of 40° (Colli-VMAT (40°)). Those of
Colli-VMAT plans with angular sections of 60° (Colli-VMAT (60°)), Colli-VMAT plans with angular sections of 40° and 60° in the previous study
(Colli-VMATPre (40°) and Colli-VMATPre (60°)), and Std-VMAT plans are plotted with dash-dot-dotted, dashed, dash-dotted, and dotted lines, respectively
Table 5 Patient-averaged values of total monitor units (MUs) and MU reduction with respect to the optimal collimator angles, and
p values for one way analysis of variance (ANOVA) with Bonferroni multiple comparison of the patient-averaged values of MU
Std-VMAT Colli-VMATPre (40°) Colli-VMATPre (60°) Colli-VMAT (40°) Colli-VMAT (60°)
Average 472 ± 235 400 ± 154 419 ± 168 390 ± 148 417 ± 167
MU reduction (%) 0.0 −15.4 −11.3 −17.4 −11.8
Bonferroni adjusted p-values
Colli-VMATPre (40°) 0.004 – – – –
Colli-VMATPre (60°) 0.011 0.029 – – –
Colli-VMAT (40°) 0.010 0.012 0.046 –
Colli-VMAT (60°) 0.023 0.057 0.356 0.047 –
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when defining the accurate outline of random targets
regardless of the shape and the number of targets in our
future studies.
Similar to our previous study, the values of field
sizes defined by the optimal collimator angles for the
Colli-VMAT (40°) plan was decreased compared to
those for the Colli-VMATPre (40°) and Std-VMAT
plans and it was demonstrated that the area size
difference between the integrated MLC aperture and
collimator settings was minimum using four con-
formal arc plans. The minimum area size difference
and reduction of the total MUs mean that the MLC
area exposed by the photon beam was smaller. It was
demonstrated that the portion of scatter and leakage
radiation to patients in treatment could be reduced
due to these effects. Several studies have reported
that the secondary cancer risk to patients may be
increased by scatter and leakage doses after introdu-
cing IMRT and VMAT techniques that use high MUs
[20–28]. Therefore, it was critical to reduce the doses
from scatter and leakage radiation. By minimizing the
area size differences and the total MUs for our study,
the clinical advantages of reduction of secondary
cancer risk from radiotherapy and comparable dosi-
metric quality of the VMAT could be expected.
As optimal collimator angles were calculated by using
the integrated MLC apertures from the conformal arc
plans, the optimal collimator angles could not be
reflected properly to that for VMAT plans. Although we
demonstrated the dosimetric improvement and MU
reduction of VMAT plans with optimal collimator angles
for multiple brain targets as well as for irregularly
shaped targets, there are limitations in applying this
technique to all cases owing to the reasons mentioned
above. In addition to this technique, there should be an
attempt to find the optimal collimator angles at various
treatment sites.
The results in this study show similarity to those of
the previous study. It has been demonstrated that the
VMAT plans using collimator trajectory achieved im-
provement of the target coverage and sparing of normal
tissue for paraspinal stereotactic body radiation therapy
(SBRT), as compared to those with a fixed collimator
angle [15]. Several studies have reported that there was
improvement on the effect of dynamic collimator angle
on the dosimetric quality to correct roll and pitch errors
in the head and neck cases, and prostate cases. They
have demonstrated that this technique could improve
planning target volume (PTV) coverage and decrease
the maximum dose to normal organs [10, 14]. Further-
more, dynamic adjustments of collimator angle during
the VMAT is the ideal way to improve delivery efficiency
and dosimetric plan quality of the VMAT plans. Con-
formal arc plans generated with four collimator settings
suggested in this study were adopted to calculate the
optimal collimator angles in the VMAT plans, and the
results of this study showed a noticeable improvement
for the dosimetric plan quality and reduction of the total
MUs as compared to Colli-VMATPre plans. If the mini-
mum angular section could be decreased in Eclipse™, the
Fig. 4 For a representative patient case (patent 6), calculated dose distribution in the axial, coronal, and sagittal views of the volumetric modulated
arc therapy (VMAT) plans with the optimal collimator angles with angular sections of 40° in the previous study (Colli-VMATPre (40°)) (a) and this study
(Colli-VMAT (40°)) (b). The target volume of Colli-VMATPre (40°) and Colli-VMAT (40°), which was the planning target volume (PTV), is shown in a
green color
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effect of optimal collimator angle suggested in this study
on dosimetric quality could be improved. This technique
should account for target outline and optimization free-
dom to shape a desired dose distribution throughout all
CPs control, and could be applied in the process of
optimization; thus, improved VMAT plans that have bet-
ter dosimetric plan quality will be generated. This will
be investigated in future studies.
Conclusions
In this study, four collimator settings of the conformal arc
plans were utilized to cover the multiple brain targets
properly and then Colli-VMAT plans with optimal colli-
mator angles were generated. The results of this study
which were dose-volumetric parameters for target volume
and normal tissues, field sizes and total MUs were com-
pared with Colli-VMAT plans, Colli-VMATPre plans and
the Std-VMAT plan. The Colli-VMAT plans with angular
sections of 40° have beneficial effects to reduce the total
MUs and spare the normal tissues. By using this tech-
nique, the Colli-VMAT plans with angular sections of 40°
could be clinically suitable for multiple brain targets.
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